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Abstract 
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative 
disease caused by a polyglutamine repeat expansion in the ATXN2 gene. We evaluated 
temporal gene profiles using RNA sequencing from mice with progressive ataxia, pcp2-
ATXN2-Q127 and found early and progressive gene expression dysregulation. 
Weighted Gene Coexpression Network Analysis revealed four modules significantly 
correlated with disease status which included modules enriched with genes associated 
with GTPase mediated signaling, calcium signaling and cell death. Additional RNA 
sequencing of a knock-out mouse model, Atxn2-/-, showed few overlapping differentially 
expressed genes when compared with the pcp2-ATXN2-Q127 model, suggesting that 
loss-of-function is not a significant  part of disease pathology. 
Introduction 
SCA2 is among the neurodegenerative polyglutamine (polyQ) diseases as it is caused 
by a CAG repeat expansion in the ATXN2 gene giving rise to an expanded polyQ 
domain(1). Other polyQ diseases include SCA1, SCA3, SCA7, SCA17, Huntington’s 
disease, spinal bulbar muscular dystrophy and dentatorubral-pallidoluysian atrophy. 
SCA2 is an autosomal dominant disorder characterized by symptoms resulting from 
neurodegeneration of the cerebellum and selective loss in the brainstem and spinal 
cord. Symptoms are characterized by progressive loss of coordination, unstable gait, 
nystagmus and dysarthria.  As is common with other SCAs, a prominent feature of 
disease progression is the loss of Purkinje neurons(2).  
Multiple transgenic mouse models have been generated to elucidate the role of ATXN2 
in SCA2(3, 4). The pcp2-ATXN2-Q127 mouse model contains 127 CAG repeats in the 
full-length ATXN2 gene under the control of the Purkinje cell targeted pcp2 promoter. 
The model showed early onset deficits in motor function as early as 8 weeks. These 
changes were preceded by electrophysiological changes at 6 weeks and gene 
expression changes at 4 weeks. The observed gene expression changes were 
identified by relying on previously established PC marker genes, genes known to be 
specifically expressed in the PCs such as Calb1 and Pcp2.  An Atxn2-CAG42 knock-in 
mouse model has also been generated(5). In contrast to the transgenic models, this 
model did not show show overt ataxic behavior, with the exception of homozygous 
knock-in animals at 18 weeks, which were associated with Pabpc1 deficiency. 
Microarray analysis of the symptomatic Atxn2-CAG42 knock-in revealed few changes in 
mRNA levels when compared to wild-type including no significant changes to the PC 
marker Calb1.  Additionally, multiple knock-out mouse lines have also been reported 
and characterized(6, 7). These loss-of-function models have been associated with 
obesity, dyslipidemia and insulin resistance.   
Generally, mouse models are used to characterize behavior over the progression of the 
disease and identify accompanying pathological features. Increasingly, models are 
being utilized to study disease progression using a system biology approach(8, 9). Such 
approaches seek to identify functional pathways involved in disease progression, 
potentially providing new therapeutic targets.  
To gain a better understanding of SCA2 disease progression, we analyzed RNA-
sequencing data from cerebella of Pcp2-ATXN2-Q127 at three distinct time points which 
represented cerebellar developmental, pre-pathological and early disease development. 
Using weighted gene co-expression network analysis (WGNCA), we identified multiple 
modules associated with disease progression including a module enriched for Purkinje 
cell transcripts and a module indicative of cell death. Additionally, we provide a 
comparison with Atxn2-/- mice showing little overlap between the two models.  
Results 
Temporal differential expression analysis of Pcp2-ATXN2-Q127  mice  
SCA2 mice are characterized by progressive worsening of molecular, motor and 
physiological phenotypes, with the earliest biochemical changes detected at 4 weeks of 
age, as described in Hansen et al (3). To further characterize the SCA2 mouse 
molecular phenotype and its progression, we analyzed gene expression by RNA 
sequencing of cerebellar tissues from Pcp2-ATXN2-Q127 (ATXN2-Q127) and age 
matched wild-type (WT) mice. Cerebellar tissue was collected at 3 time points:  an early 
developmental stage (1 day), a pre-pathological stage (3 weeks) and a stage where 
electrophysiological changes are detectable (6 weeks). RNA libraries were generated 
from multiple biological replicates from each group and subsequently sequenced on an 
Illumina HiSeq platform (see methods). We identified 146, 458 and 445 differentially 
expressed genes (DEGs) relative to WT at the day 1, week 3 and week 6 time points, 
respectively (fold change ≥ 1.5 or ≤ -1.5, p-value <0.01).  A larger number of genes had 
greater fold changes in expression occurring at later time points (Supplementary 1). Of 
the significant DEGs, few were shared across all time points, with the greatest 
percentage of shared genes occurring between weeks 3 and 6 (Fig. 1).  
Enrichment Analysis 
Gene ontology (GO) analysis using DAVID showed that the shared genes between 
weeks 3 and  6 were strongly enriched for annotations in biological process (BP), 
molecular functions (MF) and cellular components (CC) related to calcium signaling and 
ATPase activity(10, 11). In contrast to the genes shared between day 1 and week 3, the 
shared genes between week 3 and week 6 showed strong enrichment for cell growth 
and regulation. Day 1 and week 6 shared genes showed only enrichment in BP terms 
related to cell growth (Supplemental Enrichment). Globally, stronger changes in down-
regulated genes were seen compared to up-regulated genes at each time point (Fig. 1). 
GO analysis of the significantly down- and up- regulated genes at each time point 
showed that terms related to calcium ion binding were significantly enriched for the 
downregulated genes across all time points, with each time point increasing in 
significance (Supplementary Table 2).  At week 3, BP terms related to developmental 
processes were significantly enriched for downregulated genes. Terms related to 
apoptosis became significantly enriched for upregulated genes in week 6, whereas 
downregulated genes were strongly enriched for terms related to ion transport, Purkinje 
cell development and cell signaling.   
Purkinje cell specific genes are down-regulated in cerebella of SCA2 mice 
Top-ranked downregulated genes at week 6 included multiple previously-identified 
Purkinje cell markers such as Trpc3, Garnl3, Doc2b and Dner (ranked 4th, 10th, 18th, and 
22nd respectively). Of the list of known annotated Purkinje cell marker genes provided 
by Rong, Wang and Morgan(12), 7/30 were down-regulated at week 3, increasing to 
23/30 by week 6. No markers were differentially expressed at day 1 (Supplementary 
Purkinje Cell List). Early down-regulated Purkinje cell markers included Atp2a3, 
Cacna1g, Dner, Doc2b, Fgf7, Garnl3 and Pcp2.  
Upregulated genes 
Across the time points, the number of down-regulated DEGS far exceeded the number 
of up-regulated DEGs. Specifically at the 3 and 6 week time points, only 97 out of 454 
and 130 out of 434 were up-regulated, respectively. Only Casp3, Adcyap1, Coch, 
Pappa and Mbl2 were significantly up-regulated at 3 and 6 weeks with the cut-offs used 
for this analysis. Of note, both Casp3 and Adcyap1 are key in cellular response to 
stress. Also, Mbl2 was the top up-regulated gene at week 3 and the second most up-
regulated gene at week 6. The Mbl2 gene encodes for mannose binding lectin which 
has been shown to bind amyloid β peptides(13).   
Weighted gene co-expression network analysis 
To gain a better understanding of the transcriptomic changes at a systems level, we 
used weighted gene co-expression network analysis (WGCNA)(14, 15). WGCNA uses 
transcriptomic data to identify biologically meaningful gene clusters known as co-
expression modules. Co-expression modules can facilitate the finding of hub genes that 
are key drivers of module function and may correspond to biological pathways(16).   
Data from the week 3 and week 6 time points were used in the WGCNA analysis. The 
day 1 time point was not used as the large differences in developmental gene 
expression between day 1 and week 3 created physiologically implausible modules. The 
top-most variable genes (see Methods) were used as WGCNA input. Topological 
overlap was used for clustering, resulting in 16 modules, as can be seen from the color-
band underneath the cluster tree (Fig. 2A). Modules were arbitrarily assigned colors 
with sizes ranging from 90 (darkgrey) to grey (1604). The grey module consisted of 
genes that do not group into any specific module.    
Identification of modules associated with mutant polyQ-expanded ATXN2  
To identify relevant modules associated with SCA2 pathology, we assessed the 
relationship between ATXN2 mutation status and the module eigengene, a weighted 
summary of the gene expression module(17). We identified four modules, black (r = 
0.48, P = 6.7e-3), darkgrey (r = 0.67, P = 1.5e-7), darkred (r =0.79, P = 2.5e-11) and 
midnightblue (r = 0.89, P = 2.2e-16) that showed significant enrichment for genes with 
differential expression between ATXN2-Q127 and WT mice (Fig. 2, Supplementary Fig. 
2). Fig. 3 visualizes the connectivity patterns and hub genes (Table 1) of the relevant 
modules. Hub genes are identified per module using WGCNA’s intramodular 
connectivity score, a measure of the cumulative connectivity a gene has with all other 
genes in a given module. 
The black module consisted of 376 genes loosely correlated with SCA2 pathology. GO 
analysis revealed that the module was enriched with genes identified as regulators of 
small GTPase mediated signal transduction (P = 1.8e-3), mRNA transport (P = 5.2e-3) 
and phosphorylation (P = 5.4e-3).  Kegg pathway analysis showed this module to be 
enriched for axon guidance (P = 4.8e-3).   
The dark grey module contained 90 genes including multiple Purkinje cell markers 
(Calb1, Car8, Casq2, Fgf7, Gng13, Kitl, Pcp4, Stk17b, Sycp1, and Trpc3). GO analysis 
revealed enrichment of terms related to ER-nuclear signaling (P = 3.5e-3), regulation of 
apoptosis (P = 1.3e-2), and positive regulation of cell differentiation (P = 2.4e-2). 
Interestingly, many of the PC marker genes are highly connected hub genes, such as 
Calb1, Stk17b and Pcp4.  
The dark red module had 107 genes including multiple PC markers (Garnl3, Homer3, 
lcmt, Itpka, Pcp2 and Slc1a6). GO analysis revealed genes enriched with terms related 
to regulation of small GTPase mediated signal transduction (P = 5.2e-5) and 
intracellular signaling cascade (P = 4.2e-4). 
The midnight blue module had the highest correlation with disease status as determined 
by the gene significance measure. It contained 159 genes, including PC markers 
(Atp2a3, Cacna1g, Dner, Doc2b, Grid2, Inpp5a and Itpr1). Interesting enriched GO 
terms included metal ion transport (P = 5.6e-5), cerebellar PC layer development (P = 
4.1e-3) and synaptic transmission (P = 8.2e-3). Kegg pathway analysis revealed the 
module to be related to long-term depression (P = 2.5e-4), phosphatidylinositol signaling 
system (P = 2.9e-3) and the calcium signaling pathway (P = 392e-3), all pathways well 
known to be crucial for PC functioning.  
Validation of key DEGs 
We validated the relative expression levels of hub genes from the co-expression 
network analysis using quantitative RT-PCR (Fig. 4). We found that 100% of the 12 
genes analyzed were significantly differentially expressed in the cerebella of ATXN2-
Q127 mice compared to WT littermates. Validated hub genes include Smarca4, Rusc2 
from the black module, Gabbr2 from the midnightblue module, Cep76, Calb1 and PCP4 
from the dark grey module and Gabbr1, Fam21, DGKZ and Aldoc from the dark red 
module. Casp3 was also validated as significantly up-regulated at week 3.   
MicroRNAs 
Several links between microRNA (miRNA) regulation and polyglutamine repeat 
associated ataxias are known(18, 19). To identify alterations in miRNA expression 
associated with SCA2, cerebellar samples from mice 3 weeks of age and age-matched 
controls were used to isolate total RNAs. Small RNA libraries were generated from four 
biological replicates from each group and subsequently sequenced on an Illumina 
HiSeq platform (see methods). An average of 29.6 million reads was generated from the 
eight libraries, ranging from 23.1 to 36.3 million. Out of the 297 million reads, 135 were 
able to be mapped to the mouse genome (mm10). Differential expression analysis was 
performed and identified 16 annotated miRNA and four snoRNAs with a fold change 
greater than 1.5 (P <0.01). With the exception of the snoRNA Gm24895, all transcripts 
were down-regulated in cerebella of ATXN2-Q127 mice (Table 2).  
Atxn2-/- mice have few cerebellar DEGs 
Atxn2 deficient mice (Atxn2-/-) are viable and have only slight phenotypic changes 
compared to wildtype littermates(6). However, it is unknown if the non-essential role of 
ataxin-2 in mice is due to the presence of orthologs or redundant mechanisms. To 
further investigate the role of Atxn2, we analyzed gene expression using RNA 
sequencing of cerebellar tissues of Atxn2-/- and age matched wild-type mice. Cerebella 
from 1 day and 60 day old wild-type, heterozygous and Atxn2-/- mice were collected, 
each with multiple biological replicates. RNA libraries were generated from each group 
and subsequently sequenced on an Illumina HiSeq platform (see methods).  
We identified 46 differentially expressed cerebellar genes (fold change ≥ 1.5 or ≤ -1.5, 
p-value <0.01) between Atxn2-/- and age matched wild-type mice at 1 day and 11 genes 
at 60 days (Supplementary X KO expression). Only two genes were differentially 
expressed at both time points (Ubc, Gm8730). Of the DEGs, 16 were up-regulated and 
30 were down-regulated at 1 day and five were up-regulated and six down-regulated at 
60 days.  
No pathway overlap between Atxn2-/- and ATXN2-Q127 mice  
To find overlapping pathways between Atxn2-/-- and Pcp2-ATXN2[Q127] mice, we 
compared the overlap among DEG lists at each time point (Fig. 5). The remarkably few 
number of significantly changed cerebellar genes between Atxn2-/- and wild-type mice, 
in contrast to the large number of differentially expressed genes between ATXN2-
Q127and wild-type mice is consistent with the gain-of-function model for the expanded 
polyglutamate disease. 
Purkinje cell firing rates in the acute cerebellar slice in Atxn2-/- mice  
After considering the lack of phenotypic and transcriptomic similarities between the 
Atxn2-/- and ATXN2-Q127 mice, we elected to investigate electrophysiological behavior 
of Atxn2-/- Purkinje cells. This allowed the examination of the effect of Atxn2 knock-out 
on the neurophysiological phenotype using methods established by Hansen et al (3). 
We utilized noninvasive extracellular recording techniques to measure the intrinsic PC 
firing rate in cerebellar slices at ages 4, 12 and 24 weeks. The average mean firing 
frequency over populations of PCs is shown in Fig. 6 using population distributions. To 
generate the distribution, the mean firing frequency was calculated over 2 min time 
periods for multiple PCs and plotted for each age. A one second snap-shot of the firing 
frequency at each age is shown in Fig. 6. The mean firing frequency is indicated for 
each age. In contrast to Pcp2-ATXN2[Q127] animals that show a progressive slowing of 
PC firing beginning at age 8 weeks, the firing frequency remained normal in Atxn2-/- 
mice.   
Discussion 
We performed RNA sequencing analysis in an SCA2 mouse model that targets 
expression of the mutant polyQ- expanded ATXN2 to PCs. Our use of multiple time 
points and differential expression analysis showed that genes were differentially 
expressed as early as 1 day, with an increasing number of genes and greater fold-
changes at later time points. Furthermore, 16 miRNAs and 4 snoRNAs were 
differentially expressed as early as 3 weeks. These observations were all made with 
stringent cut-offs for fold-change and significance levels for multiple comparisons.  
Subsequent analysis of the DEGs using WGCNA allowed us to identify four gene 
modules related to disease progression. Investigation of these modules revealed novel 
hub genes and pathways that are likely biologically relevant to disease status.  
Comparison of the ATXN2-Q127 and Atxn2-/- expression datasets showed negligible 
overlap. Additionally, PC firing in the acute slice in the knock-out model was unchanged 
in contrast to the transgenic model in which the intrinsic firing frequency becomes 
progressively slower with age (Hansen paper). Taken together, these data give insight 
into the SCA2 disease progression, are consistent with a gain-of-toxic-function 
associated with ATXN2 mutation. Furthermore these data support ongoing research on 
the development of SCA2 therapeutics that lower ATXN2 expression targeting both wt 
and mt alleles.  
Transcriptomic comparison 
Several studies have examined changes in mRNA steady-state levels in SCA mouse 
models. Most of these used expression arrays (refs), but a recent analysis of an SCA1 
model employed RNA-seq and analysis by WGCNA(20). Transcription dysregulation 
commonly seen in polyglutamine disorders and comparison of gene expression among 
the polyglutamine diseases has revealed many commonly occurring changes(21, 22). 
We also find similarities between published polyglutamine expression profiles and our 
SCA2 profile. Everet et al. determined gene expression changes in SCA3 cell 
models(23). While not a perfect comparison, non-cerebellar genes and pathways were 
revealed. Of note, both studies demonstrated changes to extra-cellular related 
molecules such as TIMP1 and TIMP2. Our full differential expression analysis, 
discussed below, showed large changes in genes associated with the ECM occurring as 
early as day 1. This overlap suggests disruption of processes involved with the ECM 
such as cellular adhesion.  Similarly we find high overlap with laser-capture PC 
expression profiles from Huntington’s and SCA7 mice(22). Unsurprisingly, many PC 
markers are common to both sets including Calb1, Pcp4, Itpr1, Slc1a6 and PCP2. Other 
overlapping genes that are also differentially expressed in SCA1, SCA3, SCA7 or 
DRPLA include Grid2, Aloc, Fam107b, Dagla, Rgs8, Nptx1 and Plcb3. Furthermore, 
many movement disorders are associated with the dysfunction of PGC-1α, a master 
regulator of mitochondrial biogenesis. While not a polyglutamine expansion disease, 
Lucas et al. showed evidence of PC loss in a PGC-1α deficient mouse model(24). No 
overlap was found between the PGC-1α dependent transcripts, suggesting different 
roles in neurodegeneration. 
Comparison to similar studies on SCA1   
Although the disease models mentioned above provide an insight into shared 
transcriptome changes in neurodegeneration, the recently published SCA1 dataset is 
most relevant to our study(20). Ingram et al. used RNA sequencing of SCA1 mouse 
cerebellar tissues and subsequent WGCNA analysis to identify two modules related to 
SCA1 pathology, Magenta and Lt. Yellow. We found no significant overlap with the 
SCA1 Lt. Yellow module but three of our SCA2 related modules (dark grey, dark red 
and midnight blue) had significant overlap with the SCA1 magenta module. There were 
33 genes of the SCA1 magenta module that overlapped with the SCA2 dark grey 
module (p<0.001), 34 with the dark red module (p<0.001) and 51 with the midnight blue 
module (p<0.001) (Supplemental SCA1_SCA2). Using the top 100 connected genes of 
the SCA1 magenta module, we found that 92 are also in the overlapping SCA2 modules 
including multiple PC marker genes. Furthermore, we found that genes identified as 
highly interconnected or hub genes in the SCA1 magenta module were also found to be 
highly interconnected in the SCA2 modules including Fam21, Gabbr1 and Homer 3 from 
the magenta/dark red module overlap and Rgs8 and Lcmt from the magenta/midnight 
tblue overlap. To identify why one SCA1 module had significant overlap with three 
SCA2 modules, we re-analyzed our SCA2 data with increased merge cut-height and 
soft-threshold power (see methods). The re-analysis resulted in a module (purple) with 
overlap of 210 genes (Supplementary SCA1_SCA2), suggesting module differences are 
a result of WGCNA parameters and filtering choices. The SCA1 study also revealed a 
likely PC protective gene, Cck. We also detected differential expression of this gene and 
the associated receptors (Cckar, Cckbr) in our SCA2 model. 
Temporal mRNA changes 
Changes in expression as early as day 1 
The use of multiple time points allowed us to identify early changes and trends 
associated with disease pathology. We observed that presence of an expanded ATXN2 
polyQ repeat resulted in altered gene expression as early as day 1. While a smaller 
number of genes were altered compared to the later time points, a portion of these 
genes were associated with terms suggesting a disruption of normal development. For 
instance, up-regulated genes are associated with histone acetylation and chromatin 
remodeling while down-regulated genes are associated with cell adhesion and 
extracellular matrix terms. It is unknown whether the disruption caused early 
morphological differences or delayed development.  Many of the genes associated with 
cell growth and development, however, remained downregulated in mice 3 weeks of 
age. Of note, detailed morphology and physiology of transgenic cerebella did not show 
any changes prior to 6 weeks of age. 
Calcium signaling changes start early 
Irregularities in calcium signaling have been associated with multiple neurodegenerative 
diseases including SCA2 (SCA2-Lui, SCA3-Chen, SCA6-Watase). At day 1, we noted a 
downregulation in 16 genes associated with calcium ion binding. This number increased 
to 31 genes by week 3 and included a downregulation of multiple genes in the calcium 
signaling pathway (Atp2b2, Atp2a3, Adra1a, Cacna1g, Camk2a, Itpr3, Nos1, Oxtr and 
Plcb3).  
Apoptosis by week 6 
Examining the widespread expression changes occurring by week six, we noticed a 
subset of upregulated genes. These genes were largely associated with regulation of 
apoptosis including Casp3, Bid, HRK, Btg2, Hspa1, Hgf, Ntf3 and Timp1. With the 
accompanying down-regulation of many PC markers, we suggest PC degeneration 
begins to occur as early as 6 weeks, after notable dysregulation of genes associated 
with calcium signally changes. 
 
Knock-out changes 
Previous studies demonstrated that SCA2 pathogenesis was likely caused by gain-of-
toxic-function due to the expanded polyQ repeat in ATXN2 (REFS). However, the extent 
to which a loss of Atxn2 function contributed to pathogenesis was unknown.  Several 
other types of ataxias have revealed that the loss of the involved proteins does not lead 
to neurodegeneration(25, 26). Yet, the deletion of ATXN1 enhanced SCA1 
pathogenesis(27).  
Disease progression by 6 weeks causes large transcriptional changes in the ATXN2-
Q127 mouse with over 400 genes differentially expressed when compared with WT. In 
contrast, relatively small changes were seen in the knock-out mouse model with only 11 
genes differentially expressed when compared with WT at an age when the transgenic 
mouse shows significant disease. Comparing the overlap between Atxn2-/- and  ATXN2-
Q127 transcriptomes at the later time point shows five out of the ten  Atxn2-/- DEGs 
were shared with Pcp2-ATXN2Q[Q127]  While this overlap is significant, the small 
number of expression changes argues strongly that loss-of-function is not a significant  
part of disease pathology. In addition, the day 1 comparison had only three overlapping 
genes.  The lack of overlap is consistent with a gain-of-function in SCA2 mice. In 
contrast to transcriptome analyses of SCA1 mice indicating gain-of-function with partial 
loss of function(27), we could find little evidence for partial loss of function in our SCA2 
mice. These conclusions based on transcriptome analyses were also supported by the 
lack of PC firing changes in the acute cerebellar slice in knockout animals. Whereas 
Pcp-ATXN2[Q127] animals show a progressive decline in spontaneous PC firing 
beginning at 8 weeks of age, PCs in Atxn2-/- mice retained a normal firing rate even as 
late as 24 weeks of age.  
WGCNA 
WGCNA is a technique used to identify highly correlated gene modules which can be 
related to external factors such as disease status. We applied this unsupervised, 
hypothesis-free method to construct co-expression networks in polyQ expanded SCA2, 
revealing pathologically relevant gene modules. This approach has been used 
successfully in a number of neurodegenerative diseases, helping to elucidate disease 
pathways and associated genes (28–31). In SCA2, little is known about gene 
expression changes that precursor electrophysiological and motor phenotype in SCA2 
disease progression. The use of a hypothesis-free approach allowed us to increase the 
current knowledge of expanded polyglutamine pathology in SCA2 and provide new 
avenues for future research.  
Modules 
We identified four modules correlated with disease status that can be summed into 
known pathological associations with SCA2 including GTPase mediated signaling, 
calcium signaling and cell death. Interestingly, the largest of these, Black, did not 
contain any PC markers. It contained multiple genes associated with regulation of small 
GTPase signal transduction (Plekhg3, Smap2, Bcr, Sgsm1, Tbc1d9, Tiam1, Prex1, Trio, 
Agap1, Tbc1d22b, Rapgef1, Arhgef11), synaptogenesis (App, Nrxn2, Dlg4) and axon 
guidance (Ablim1, Ablim2, Sema4g, Unc5a, Plxnb3, Sema4b, Sema4d, Sema3a). This 
module provides an insight into the dysregulation of neurodegenerative cell morphology. 
The darkred module is similarly associated with regulation of GTPase mediated signal 
transduction (Garnl3, Agfg2, Rapgef6, Iqgap2, Dgkz, Icmt, Cyth3, Psd2). However, it 
was not found to be enriched for any other GO term or KEGG pathways. The dark grey 
module is enriched for genes associated with programmed cell death (Trp53, Stil, Clu, 
Stk17b, Eif2ak3, Kitl, Acvr1c). It provides additional information on the early apoptotic 
cycle in the cerebellum. Of note, pathway analysis of this module showed an overlap 
with pathways associated with cancer due to the genes TRP53, CCND1, FGF7, and 
ACVR1C. Also, three of the top four genes ranked by intermodular connectivity, or hub 
genes, are known PC markers Calb1, Stk17b and Pcp4 providing evidence that further 
analysis of this module may provide novel PC markers. Lastly, the midnight blue module 
is significantly associated with calcium signaling (Atp2b2, Plcb3, Atp2a2, Atp2a3, 
Cacna1g, Grm1, Itpr1) and PC layer development (Atp2b2, Lhx5, Klhl1). Further 
investigation into this module could elucidate early transcriptional changes in PCs. This 
module also had overlap with an Alzheimer’s disease pathways. Complete GO term 
categories and associated genes can be found in the supplemental material (STXX).  
microRNAs in Neuro 
Finally, the identification of early transcriptional changes in miRNAs presents 
opportunities for further investigation into disease pathogenesis. MiRNAs and snoRNAs 
have important roles in many neurodegenerative diseases, including Parkinson’s, 
amyotrophic later sclerosis (ALS) and Alzheimer’s disease (19, 32). Our results at 3 
weeks of age show changes in 16 annotated miRNAs and 4 snoRNAs including 
Snord115 which has a decrease of over eight-fold when compared with WT.Since 
Snord115 is a gene cluster containing at least 130 copies in mouse, it is likely that the 
difference in expression is due to sequencing alignment error. However, previous 
studies have demonstrated increased expression of Snord115 correlate with increased 
calcium ion response to GPCR mediated signaling (Autism-nakatani).Considering the 
notable changes to genes associated with calcium signally at 3 weeks of age, it is 
plausibly that the large decrease of this snoRNA in ATXN2-Q127 is in response to an 
early imbalance in calcium signaling. Further research is needed.   
Materials and Methods 
RNA Sequencing and analysis 
Total RNA was isolated using miRNeasy Mini Kit (Qiagen Inc., USA) according to the 
manufacturer’s protocol. RNA quality was determined using the Bioanalyzer2100 Pico 
Chip (Agilent). Samples with an RNA integrity number (RIN) >8 were used for library 
preparation using Illumina TrueSeq Stranded Total RNA Sample Prep with Ribo-Zero 
rRNA Removal Kit for mouse. Single-end 50-bp reads were generated on a Hiseq 2000 
sequencing machine at the University of Utah Microarray and Genomic Analysis Shared 
Resource using Illumina Version 4 flow cells. Reads were then aligned to the mouse 
reference genome (mm10) by Novoalign (http://www.novocraft.com). Quality of RNA 
sequencing was good with an average of twenty two million reads for Pcp2-
ATXN2[Q127]. Ninety eight percent of the reads were aligned to the reference mouse 
genome.  After read alignment, differentially expressed genes were identified using the 
DRDS application (version 1.3.0) in the USeq software package 
(http://useq.sourceforge.net/). 
Co-expression network 
RNA-seq data from the week 3 and week 6 timepoints were first filtered by FPKM (≥ 1.0 
in 90% of samples) to reduce noise. Further filtering on the coefficient of variation (≥ 
0.15) was used to get the most variable genes, resulting in 7694 transcripts. The 
unsigned WGCNA was conducted as previously described using the R package 
WGCNA (PMID 19114008). Briefly, a similarity matrix was constructed using the 
Pearson correlation coefficients created between the FPKM normalized expression 
levels of the input transcripts. By raising the absolute value of the Pearson correlation 
coefficients to a power of 14, we were able to get a scale-free topology index above 0.9, 
achieving a network with few, large correlations at the expense of lowly correlated 
transcripts. This allows for the fewer, highly connected and biologically relevant hub 
genes. An adjacency network was then created using topological overlap measure 
(TOM), a measure of neighborhood connectivity. To create modules, the adjacency 
network was converted into a dissimilarity measure (1 – TOM) and clustered using 
flashClust, a hierarchical clustering function. Cluster branches were cut to identify 
modules. Module size was set to a minimum of 50 transcripts and modules with a 10% 
similarity were merged using dynamic tree cutting, resulting in 16 modules. To identify 
significant modules, Gene Significance (GS) was calculated as the absolute value of the 
correlation between gene expression and transgenic status. Overall significance for 
each module was calculated by averaging all GS within each module. Statistical 
significance was determined using the correlation t-test p-value.  
RNA expression analyses by quantitative RT-PCR 
Mice were deeply anesthetized with isoflurane. Mouse cerebella were removed and 
immediately submerged in liquid nitrogen. Tissues were kept at −80°C until the time of 
processing. Total RNA was extracted from mouse cerebella using the RNeasyMini Kit 
(Qiagen Inc., USA) according to the manufacturer’s protocol. DNAse I treated RNAs 
were used to synthesize cDNAs using the ProtoScript cDNA First Strand cDNA 
Synthesis Kit (New England Biolabs Inc., USA). Quantitative RT-PCR was performed in 
Bio-Rad CFX96 (Bio-Rad Inc., USA) with the Power SYBR Green PCR Master Mix 
(Applied Biosystems Inc, USA). PCR reaction mixtures contained SYBR Green PCR 
Master Mix and 0.5 pmol primers and PCR amplification was carried out for 45 cycles: 
denaturation at 95°C for 10 sec, annealing at 60°C for 10 sec and extension at 72°C for 
40 sec. The threshold cycle for each sample was chosen from the linear range and 
converted to a starting quantity by interpolation from a standard curve run on the same 
plate for each set of primers. All gene expression levels were normalized to the Actin 
mRNA levels. Primer pairs designed for qRT-PCR are given as forward and reverse, 
respectively, and listed in supplementary table. (Sharan will send) 
Functional Enrichment Analysis 
Gene Ontology and pathway-enrichment analysis (KEGG) was conducted using the 
functional annotation tool DAVID (https://david.ncifcrf.gov/). Enriched ontological terms 
and pathways with a P value less than 0.05 were selected.   
MircoRNA  
Cerebellar extract from mice 3 weeks of age with 4 biological replicates and age-
matches WT controls were used for microRNA library construction. The construction of 
Small RNA sequencing libraries was performed using the Illumina TruSeq Small RNA 
Sample Prep Kit (RS-200-0012, RS-200-0024).  Most mature miRNAs have a 5'-
phosphate and a 3'-hydroxyl as a result of the cellular pathway that creates them.  The 
adapters are designed to specifically ligate to RNA molecules containing these terminal 
modifications.  Briefly, total RNA (1 ug) was denatured and 3' and 5' RNA adapters were 
sequentially ligated to appropriately modified ends of RNA molecules.  Adapter-ligated 
RNA was reverse transcribed using a RNA primer complimentary to the 3'-adapter 
sequence and Superscript II Reverse Transcriptase (Invitrogen cat#18064-
014).  Adapter sequences were extended and index tags are added to the reverse 
transcribed cDNA by pcr (11 cycles).  The pcr-amplified library is resolved on a 6%25 
Novex TBE PAGE gel (Invitrogen cat#EC6265BOX) and a gel fragment 
representing   the size range of adapter-modified small RNA cDNA was excised from 
the gel.  Small RNA library molecules were eluted by soaking the crushed gel fragment 
overnight in ultra-pure water at room temperature.  Gel debris was removed from the 
eluate by centrifugal filtration of the sample across a 5 um filter.  The concentration of 
the small RNA library was  measured using the Invitrogen Qubit dsDNA HS Assay 
(Q32851) and an aliquot of the library was resolved on an Agilent 2200 Tape Station 
using a High Sensitivity D1K (cat# 5067-5363 and 5067-5364) assay to define the size 
distribution of the sequencing library.  Libraries were adjusted to a concentration of 
approximately 5 nM and quantitative PCR was performed using the KapaBiosystems 
Kapa Library Quant Kit (cat# KK4824) to calculate the molarity of adapter ligated library 
molecules.  The concentration was further adjusted following qPCR to prepare the 
library for Illumina sequence analysis.  
Electrophysiology 
Parasagittal cerebellar slices were made as described earlier in Hansen et al (3). In 
brief, age-matched WT and ATXN2-KO mice were anesthetized using isoflurane and 
decapitated in accordance with the protocol approved by the University of California Los 
Angeles Institutional Animal Care and Use Committee. The cerebellum was quickly 
dissected and placed in ice-cold extracellular solution (with composition in mM: 119 
NaCl, 26 NaHCO3, 11 glucose, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2 and 1 NaH2PO4, pH 7.4 
when gassed with 5% CO2 and 95% O2). Parasagittal cerebellar slices (285-μm 
thickness) were prepared on a Leica VT1000 vibratome (Leica, Germany) in ice-cold 
extracellular solution.  Cerebellar slices were then incubated at 35 °C for 30 min and 
stored at room temperature until use. Temperature was set to  34.5+1°C (Model TC-
344B, Warner Instruments) in the recording chamber and perfused cerebellar slices with 
extracellular solution at a rate of 2.8-3 ml/min. Purkinje cells were visualized with an 
upright microscope (Leica) using 40x water immersion objective. Recordings were 
carried out with borosilicate glass electrodes (World Precision Instruments, USA) of 2–3 
MΩ pulled on a P-1000 instrument (Sutter, USA) and filled with extracellular solution, 
the pipette potential was held at 0 mV and placed close to the axon hillock (soma/axon) 
of a Purkinje cell to measure action potential-associated capacitative current transients 
in voltage clamp mode for 2 minutes and typically 50 to 120 PCs were measured from 
three to six mice per genotype and the experimenter was kept blinded to the genotype. 
Currents were filtered at 4 kHz and sampled at 20 kHz using a Digidata 1440 and 700B 
amplifier (Axon Instruments). Spike detection was performed in pClamp 10 and further 
analysis Microsoft Excel or Igor software was used. Results are expressed as 
mean+SEM and figures are made in Igor program. 
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Figure Legends 
Figure 1. Overview of gene expression profiles of cerebellar tissue of ATXN2-
Q127 mice at three time points. (A) Number of shared and specific differentially 
expressed genes across three time points. (B) Number of up- (red) and down- (green) 
differentially regulated genes in cerebella of ATXN2-Q127 mice compared to WT mice 
at each time point.  
Figure 2.  Gene co-expression modules. (A) Identification of gene co-expression 
modules in ATXN2-Q127 mice with age matches controls. Branches of the cluster 
dendrogram gave rise to 16 color-coded modules when modules with 10% similarity 
were merged. (B) Gene significance per module as determined by enrichment for genes 
with high differential expression between ATXN2-Q127 and controls. The black, 
darkgrey, darkred and midnightblue modules were the only significant modules as 
determined by P-value less than 0.05.  
Figure 3.  Co-expression network of relevant modules. Network representation of 
(A) black (B) darkgrey (C) darkred and (D) midnightblue modules. Visual representation 
generated using VisANT (REF). Given TOM cut-offs, not all genes corresponding to 
each module are represented.  
Figure 4. Validation of key genes. Needs updated with p-values.   
Figure 5.  Comparison of differentially expressed genes between mouse models. 
Venn diagrams of differentially expressed genes (Het = heterozygous for Atxn2, 
TG=ATXN2-Q127 and KO= Sca2(-/-)) at 1 day and 60 day/6 week time points models.   
Figure 6.  Knockout of the Atxn2 gene in mice did not change  Purkinje cell firing 
in the acute cerebellar slice Purkinje cell firing frequency distribution plot determined 
by extracellular recordings in acute cerebellar slices from Atxn2 knockout mice ages 4, 
12, and 24 weeks of WT (A) and SCO2-KO (B). Alexa dye filled Purkinje Neuron in WT 
(C) and SCA2-KO (D) in 24 wks old mice. 
 
Tables 
Table 1. Top 10 hub genes as ranked by intramodule connectivity for each of the 
gene significant modules 
Black Darkgrey Darkred Midnightblue 
Smarca4 Cep76 Cyth3 Gabbr2
Rusc2 Calb1 Dgkz Dagla 
Pcdhga9 Stk17b Gabbr1 Doc2b 
Ankrd11 Pcp4 Sbk1 Atp2a2 
Lmtk2 Dpp10 Fam21 Prkcg 
Sptb Kcnab1 Icmt Atp2b2 
Dnm1 Ppp1r17 Rnf19b Mprip 
Cep170b Cep72 Garnl3 Cacna1g 
Phf2 Gm13944 Aldoc Arhgap26 
Agap1 Arhgef33 Homer3 Shank2 
 
Table 2. Differentially expressed miRNA and snoRNA at 3 weeks.  
Gene Name Gene Biotype Location Fold Change 
snord115 snoRNA chr7:59389819-59389898 23.85819509 
snord115 snoRNA chr7:59424923-59425002 15.60283195 
snord115 snoRNA chr7:59353282-59353361 9.942481689 
snord115 snoRNA chr7:59436148-59436227 3.796002651 
snord115 snoRNA chr7:59423054-59423133 3.396808767 
Mir199b miRNA chr2:32318459-32318569 2.462080615 
Mir203 miRNA chr12:112130879-112130955 2.628937784 
Mir499 miRNA chr2:155622879-155622958 2.157976269 
Mir1197 miRNA chr12:109712316-109712436 2.593526301 
Mir142 miRNA chr11:87756863-87756927 2.602084838 
Mir1193 miRNA chr12:109715670-109715791 2.13206881 
snord116 snoRNA chr7:59681054-59681148 2.592665348 
Mir144 miRNA chr11:78073004-78073070 2.618330112 
Mir653 miRNA chr6:3721300-3721385 2.47143335 
Mir544 miRNA chr12:109729324-109729402 2.165544772 
Mir208a miRNA chr14:54949059-54949142 2.038487344 
Gm24895 snoRNA chr12:109646128-109646202 0.47198241 
Mir669l miRNA chr2:10468970-10469068 1.934303262 
Gm22620 snoRNA chr9:15315188-15315321 1.850769206 
Mir133b miRNA chr1:20682768-20682887 1.909787341 
Mir214 miRNA chr1:162223367-162223477 2.038867469 
Mir3059 miRNA chr10:101772691-101772772 2.309486319 
Mir483 miRNA chr7:142654923-142654996 1.847473922 
Mir708 miRNA chr7:96249423-96249532 2.203793429 
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